Advertise
CapsCanada
SOHO Expo

Click Here for the Latest Episode of the Vitamin Professor Podcast Hosted by Gene Bruno

Senators Ask FDA to Update Rules on Certain CBD Products

by Nicholas Saraceno | February 4, 2019

Oregon’s two senators urged the head of the U.S. Food and Drug Administration to update federal regulations to permit interstate commerce of food products containing a key non-psychoactive ingredient of cannabis, via AP.

The appeal by Sens. Ron Wyden and Jeff Merkley came after Congress legalized the production and sale of industrial hemp and hemp derivatives, including cannabidiols, known as CBD. Wyden and Merkley had been behind a hemp provision that Congress passed and was included in the 2018 Farm Bill.

But after President Trump signed the bill in December, FDA Commissioner Scott Gottlieb restated his agency’s stance that CBD is a drug ingredient and therefore illegal to add to food or health products without his agency’s approval. The FDA has sent warning letters to some companies making health claims for CBD.

In a letter to Gottlieb, the senators asked the FDA to update “outdated regulations” that prohibit food products containing CBD from being sold across state lines.

“Farmers in Oregon and nationwide are poised to make real economic gains for their communities once these regulations are updated,” they wrote. They said it was Congress’ intent in the bill to ensure producers and consumers have access to hemp-derived products, including CBDs.

The Oregon Democrats asked the agency to clarify to the public several issues, including its authority in the production and marketing of hemp and its derivatives, and whether the FDA will consider issuing a regulation to allow hemp derivatives in food, beverages or dietary supplements that cross state lines.

Scientists note there have been few comprehensive clinical studies on how CBD affects humans. Harvard Medical School said the strongest scientific evidence is for its effectiveness in treating childhood epilepsy syndromes, which typically don’t respond to anti-seizure medications. The FDA recently approved the first ever cannabis-derived medicine for these conditions which contains CBD. Studies suggest CBD may also help those with insomnia to fall asleep and stay asleep.

Don't Miss Out!

Sign up for Vitamin Retailer Digital Newsletter
Digital Newsletter
Subscribe to Vitamin Retailer Magazine
Vitamin Retailer Magazine

Industry Professionals
Stay Informed!

Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Vitamin Retailer magazine and digital newsletter.

Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.

Featured Listing:


CapsCanada

Subscribe To Our Newsletter

Stay Informed! Breaking news, industry trends featured topics, and more.

Subscribe to our newsletter today!